Home » Stocks » CVRX

CVRx, Inc. (CVRX)

CVRx will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) 7.20M
Net Income (ttm) -18.92M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

CVRx, Inc. has filed to go public with an IPO on the NASDAQ.

2 weeks ago - SEC

About CVRX

CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Our second-generation product, BAROSTIM NEO, is the first and only commercially available neuromodulation device indicated to improve symptoms for patients with heart failure (“HF”) with reduced Ejection Fraction (“HFrEF”), or systolic HF. BAROSTIM NEO provides Baroreflex Activation Therapy (“BAROSTIM Therapy”) by sending impe... [Read more...]

Industry
Medical Devices
IPO Date
Pending
CEO
Nadim Yared
Employees
63
Stock Exchange
NASDAQ
Ticker Symbol
CVRX
Full Company Profile

Financial Performance

In 2020, CVRx's revenue was $6.05 million, a decrease of -3.26% compared to the previous year's $6.26 million. Losses were -$14.11 million, -3.58% less than in 2019.

Financial Statements